Crenolanib and Intensive Chemotherapy in Adults With Newly Diagnosed FLT3-Mutated AML

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Genomic Classification and Prognosis in Acute Myeloid Leukemia2016 · 4,535 citations
2. 2The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials2001 · 1,559 citations
3. 3Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm2002 · 869 citations
4. 4Differential impact of allelic ratio and insertion site in FLT3-ITD–positive AML with respect to allogeneic transplantation2014 · 405 citations
5. 5Prognostic significance of baseline <i>FLT3</i>‐ITD mutant allele level in acute myeloid leukemia treated with intensive chemotherapy with/without sorafenib2019 · 34 citations